http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10488417-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_751430a32763964dbc7195a2d58cffbc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2835
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2814
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-216
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
filingDate 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2cc3dc50689d50429796a3a35de2ee1
publicationDate 2019-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10488417-B2
titleOfInvention Compounds for use as imaging agents
abstract The present invention describes the use of the Chinese medicinal compounds ginsenoside RB1, dihydromyricetin and salvianohc acid B, for use in diagnosing, monitoring and treating synucleinopathies, such as Parkinson's disease, in patients.
priorityDate 2014-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014241984-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009238902-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012053235-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9950300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012251448-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009027690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000191539-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011159527-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014132210-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03069332-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID132043089
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454177458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452207392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID89751000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585602

Total number of triples: 47.